Organization
Nanfang Hospital, Southern Medical University
41 clinical trials
Clinical trial
Efficacy and Safety of Dapagliflozin in Non-alcoholic Steatohepatitis: a Multicentre, Randomized, Placebo-controlled TrialStatus: Completed, Estimated PCD: 2024-03-22
Clinical trial
Efficacy and Safety of Neoadjuvant Cadonilimab and Chemotherapy for Locally Advanced Esophagogastric Junction and Gastric Cancer : a Prospective, Open-label, Single-Arm Phase II StudyStatus: Not yet recruiting, Estimated PCD: 2025-03-01
Clinical trial
Adjunctive Esketamine for Analgesia in Mechanically Ventilated ICU Septic Shock PatientsStatus: Recruiting, Estimated PCD: 2024-10-31
Clinical trial
Efficacy and Safety of Rivaroxaban in the Prevention of Venous Thromboembolism in Glioma Patients With Postoperative Lower Extremity DyskinesiaStatus: Recruiting, Estimated PCD: 2024-08-31
Clinical trial
A Double-blind Randomized Controlled Trial of Adenosine Disodium Triphosphate in Improving Moderate to Severe DepressionsStatus: Recruiting, Estimated PCD: 2026-12-31
Clinical trial
Cardioprotective Effects of Cardiopeptides for Injection in Patients With Non-severe Cardiac Disease: a Single-center Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2023-11-25
Clinical trial
Doxepin Solution for Alleviation of Stubborn Breakthrough Pain Induced by Swallowing in Patient Receiving Radiotherapy for Nasopharyngeal Carcinoma: A Multicenter, Randomized, Controlled, Double-Blind Clinical TrialStatus: Recruiting, Estimated PCD: 2024-08-30
Clinical trial
A Phase Ⅱ Exploratory Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy as First-Line Treatment for Extensive-Stage Oligometastatic Small Cell Lung CancerStatus: Recruiting, Estimated PCD: 2026-06-30
Clinical trial
A Phase II,Single-arm Study to Evaluate the Safety and Efficacy of Pembrolizumab and Stereotactic Radiotherapy (SBRT) in Patients Advanced Metastatic Renal Clear Cell Carcinoma.Status: Recruiting, Estimated PCD: 2024-10-31
Clinical trial
A Clinical Study on the Efficacy and Safety of Amphotericin B Cholesteryl Sulfate Complex for Injection in the Empirical First-line Treatment of Patients With Invasive Fungal DiseasesStatus: Not yet recruiting, Estimated PCD: 2025-02-01
Clinical trial
Tislelizumab Plus CapeOX ± Lenvatinib as First-Line Treatment for Advanced GC/GEJC With Positive PD-L1 and Low TMEscore: A Multi-center, Prospective, Phase II StudyStatus: Recruiting, Estimated PCD: 2026-08-01
Clinical trial
Toripalimab Maintenance After First-line Comprehensive Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma: a Single-arm, Phase II StudyStatus: Not yet recruiting, Estimated PCD: 2026-02-01
Clinical trial
Clinical Study on Evaluating the Safety and Tolerability of Bispecific Antibody MR001 in Patients With Advanced Solid Tumors.Status: Not yet recruiting, Estimated PCD: 2026-07-01
Clinical trial
Fluoxetine Combined With ATP Rapidly Improves Moderate to Severe Depression: a Pilot StudyStatus: Recruiting, Estimated PCD: 2025-12-30
Clinical trial
Combined Therapy Using Gemcitabine and Cisplatin Chemotherapy, Lenvatinib and Adebrelimab for Patients With Advanced and Unresectable Intrahepatic Cholangiocarcinoma: a Prospective, Single-arm, Phase II Trial.Status: Recruiting, Estimated PCD: 2025-02-25
Clinical trial
RemImazolam Besylate for ICU-sedation in Patients With Mechanical Ventilation After Oral and Maxillofacial Surgery: Multicenter, Randomized, Non-inferiority Clinical StudyStatus: Recruiting, Estimated PCD: 2024-03-31
Clinical trial
Single-arm, Prospective Clinical Study of PD-L1 Inhibitor Combined With Apatinib as First-line Maintenance Treatment for Extensive-stage Small Cell Lung CancerStatus: Not yet recruiting, Estimated PCD: 2026-04-30
Clinical trial
Clinical Study of hAESCs on Prevention of Acute Graft-versus-host Disease After Hematopoietic Stem Cell TransplantationStatus: Not yet recruiting, Estimated PCD: 2025-07-31
Clinical trial
Anlotinib in Combination With Toripalimab and Chemotherapy for Neoadjuvant Treatment of Resectable Esophageal Squamous Cell Carcinoma: a Phase II Clinical StudyStatus: Not yet recruiting, Estimated PCD: 2024-11-01
Clinical trial
Comparing Ciprofol and Propofol for Sedation in Hypotensive ICU Patients: a Single Center Prospective Cohort StudyStatus: Recruiting, Estimated PCD: 2024-10-01
Clinical trial
Toripalimab Combined With Neoadjuvant Chemoradiotherapy as First-line Treatment for Locally Advanced，High-Risk，MSS Rectal CancerStatus: Recruiting, Estimated PCD: 2025-01-01
Clinical trial
Cadonilimab Plus CapeOX as First-Line Treatment for Advanced GC/GEJC With High Tumor Microenvironment Score (TMEscore).Status: Not yet recruiting, Estimated PCD: 2026-04-01
Clinical trial
Association of Osmotic Drugs With Clinical Outcomes in Acute Large Hemispheric Infarction: a Prospective, Multicenter, Observational Cohort StudyStatus: Not yet recruiting, Estimated PCD: 2027-01-01
Clinical trial
Exploratory Clinical Study of Orelabrutinib in Combination With BG Regimen in Patients With Naive and Unfit CLL/SLL Without 17p- or TP53 MutationsStatus: Not yet recruiting, Estimated PCD: 2024-12-30
Clinical trial
Camrelizumab After Completion of Radiotherapy for Oligometastatic Nasopharyngeal Carcinoma: A Phase 2 TrialStatus: Recruiting, Estimated PCD: 2024-02-01
Clinical trial
Application of Pirfenidone as a Radiosensitizer in the Treatment of Head and Neck Squamous Cell Carcinoma: Phase II Clinical StudyStatus: Recruiting, Estimated PCD: 2025-01-30
Clinical trial
Efficacy and Safety of Postoperative Adjuvant Chemotherapy Combined With Camrelizumab for Patients With ⅡA -ⅢA Non-small Cell Lung Cancer：a Phase II , Single-arm Clinical StudyStatus: Recruiting, Estimated PCD: 2026-04-01
Clinical trial
Intensity-modulated Radiation Therapy Combined With Cisplatin-based or Carboplatin-based Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma：: A Phase 3 TrialStatus: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
Safety and Efficacy of Glibenclamide Combined With Rt-PA in Treating Acute Ischemic Stroke: a Prospective, Randomized, Double-blind, Placebo-control, Multi-center StudyStatus: Completed, Estimated PCD: 2022-08-28
Clinical trial
CD19-Chimeric Antigen Receptor-T2 Cells for CD19 Positive Acute Lymphoblastic LeukemiaStatus: Recruiting, Estimated PCD: 2023-06-30
Clinical trial
REmimazolam vs Propofol Total Intravenous Anesthesia on Outcomes After Major Noncardiac SurgEry (REPOSE-2): A Multicenter Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Efficacy and Safety of Iguratimod Combined With Tofacitinib in the Treatment of csDMARD-IR Patients With Active Moderate-to-severe Rheumatoid Arthritis： a Prospective, Randomized, Controlled, Multicenter StudyStatus: Not yet recruiting, Estimated PCD: 2025-01-30
Clinical trial
A Single-arm, Open-label Study of Olverembatinib, CD3/CD19 Bispecific T-cell Engager, and Chidamide in Patients With Newly Diagnosed Philadelphia Chromosome-positive Acute Lymphoblastic LeukemiaStatus: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
A Multicenter Prospective Cohort Study Study of CLAG Regimen in Acute Myeloid Leukemia Patients With First-induction FailureStatus: Not yet recruiting, Estimated PCD: 2027-08-20
Clinical trial
Shugan Jieyu Capsule for Insomnia Patients With Depressive Symptoms: A Randomized Double Blind Controlled StudyStatus: Recruiting, Estimated PCD: 2024-12-30
Clinical trial
Precision Chemotherapy Based on Organoid for Colorectal CancerPatient-Derived Tumor Organoid Drug Sensitivity for Colorectal Cancer: A Prospective, Multicentre，Randomized, Controlled TrialStatus: Recruiting, Estimated PCD: 2025-01-01
Clinical trial
Efficacy and Safety of Neoadjuvant Pembrolizumab in III-IVA Resectable Oral Squamous Cell CarcinomaStatus: Recruiting, Estimated PCD: 2023-12-31
Clinical trial
Research on the Mechanisms of Treatment Non-response in Inflammatory Bowel Disease Based on Multi-omics TechnologyStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
G-CSF+DAC+BUCY vs. G-CSF+DAC+BF Conditioning Regimen for Patients With High-risk MDS Undergoing Allogeneic Hematopoietic Stem Cell TransplantationStatus: Recruiting, Estimated PCD: 2023-12-01
Clinical trial
Efficacy and Safety of Sodium Oligomannate in the Prevention of Post-stroke Cognitive Impairment in Patients With Ischemic Stroke:a Randomized, Double-blind, Exploratory Controlled StudyStatus: Not yet recruiting, Estimated PCD: 2023-12-31
Clinical trial
Safety and Superiority of Penicillamine in Radiosensitization of Recurrent Head and Neck Cancer: a Single-center, Single-arm, Phase II Clinical TrialStatus: Recruiting, Estimated PCD: 2024-10-30